JUNE 3, 2026

The 5 Best Dividend Aristocrats to Buy in 2026

The 5 Best Dividend Aristocrats to Buy in 2026

Summary

Dividend aristocrats, known for their consistent dividend growth over 25 years, can mislead investors into thinking they are the best long-term picks. However, even these companies can cut dividends, as seen with Walgreens Boots Alliance. To mitigate risk, focus on firms with wide economic moats. Notable recommendations include Clorox, Medtronic, Brown-Forman, McCormick & Co, and Kimberly-Clark, all trading below fair value estimates, offering potential for solid returns.



Disclosure: This article is for informational and educational purposes only and is not financial, investment, tax, or legal advice. References to specific securities, tickers, companies, or strategies are provided for informational purposes only and do not constitute a recommendation, solicitation, or offer to buy or sell any security or financial product. We do not provide individualized advice or act as a fiduciary. Investing involves risk, including loss of principal, and past performance is not indicative of future results. We may hold positions in securities mentioned. You should independently verify information before acting on it and consult a qualified professional as needed.